HR Execs on the Move

Baxalta

www.baxalta.com

 
Newly combined with Baxalta, Shire is now the leading global biotechnology company focused on serving people affected by rare diseases and highly specialized conditions. These diseases are often misunderstood, under-diagnosed, and potentially life-threatening. Our 22,000 employees come to work every day with a common purpose: to develop and deliver breakthrough therapies that enable people with life-altering conditions to live their lives to the fullest. At Shire, we are dedicated to expanding, building and sustaining leadership across our key therapeutic areas through our extensive portfolio of products, innovative pipeline and collaborative approach to working with diverse partners around the globe. We strive to ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.baxalta.com
  • 1200 Lakeside Dr
    Bannockburn, IL USA 60015
  • Phone: 224.948.2000

Executives

Name Title Contact Details
Patricia Prospero
 Head of Human Resources Profile

Similar Companies

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic

Mission Hill

Deep Hospitality Knowledge Mission Hill Hospitality is the KSL Capital portfolio company launched to transform select service and extended stay hotel investing. KSL is a global leader in hospitality, travel, and leisure investing. The Mission Hill team has decades of lodging experience, with a wide range of expertise across functions including operations, asset management, acquisitions, development, and capital markets. Industry Advantage Mission Hill`s approach combines the benefits of KSL`s world-leading, world-class hospitality model, with our seasoned team`s broad relationships with owners, managers, premium brands, and developers, enabling us to create the highest quality asset portfolio. Value Added Mission Hill`s value-add strategy seeks to maximize the performance of each investment while elevating the client experience. By hand-picking assets in preferred markets across the country, we avoid inherent information asymmetry and premiums associated with acquiring a portfolio. Our disciplined approach to underwriting gives us the ability to secure outsized risk adjusted returns.

Mulberry Grove

Mulberry Grove is a Statham, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Century Care Ctr

Century Care Ctr is a Century, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

International Regulatory Consultants

International Regulatory Consultants, L.C. is a Midvale, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.